ClinicalTrials.gov
public full text
Public Domain
Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19
To conduct an open-label randomized controlled trial on a short course of interferon β-1b and clofazimine combination treatment for patients hospitalized for COVID-19 infection. To assess its safety and clinical efficacy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2#813186
- IFN-beta 1b and Remdesivir for COVID19#1096947
- Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19#913088
- IFN Beta-1b and Ribavirin for Covid-19#1127204
- Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study#802731
Record · ID 873331
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive